Vanguard Personalized Indexing Management’s Royalty Pharma RPRX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Buy	6,652 +743	+13%	+$38.7K	﹤0.01%	1574
2026 Q1	$283K	Buy	5,909 +181	+3%	+$7.93K	﹤0.01%	1641
2025 Q4	$221K	Buy	+5,728	New	+$218K	﹤0.01%	1685
2022 Q4	–	Sell	-5,371	Closed	-$216K	–	1324
2022 Q3	$216K	Sell	5,371 -156	-3%	-$6.66K	0.01%	1083
2022 Q2	$232K	Buy	+5,527	New	+$227K	0.01%	1076
2022 Q1	–	Sell	-21,079	Closed	-$840K	–	1231
2021 Q4	$840K	Buy	+21,079	New	+$819K	0.05%	481

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Personalized Indexing Management's RPRX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Royalty Pharma (RPRX) stake by 13% in Q2 2026, buying an estimated $38.7K and bringing the position to 6,652 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Vanguard Personalized Indexing Management first reported a position in RPRX in Q4 2021 and has held it in 6 quarters since. The position peaked at $840K in Q4 2021. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Vanguard Personalized Indexing Management held 6,652 shares of Royalty Pharma worth $373K as of Q2 2026.
Vanguard Personalized Indexing Management bought 743 Royalty Pharma shares in Q2 2026, an estimated $38.7K.
Royalty Pharma made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1574 holding.
Vanguard Personalized Indexing Management first reported a position in Royalty Pharma in Q4 2021 and has held it in 6 quarters since.
Vanguard Personalized Indexing Management's Royalty Pharma position peaked at $840K in Q4 2021.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.